共 50 条
Surveillance for Colorectal Neoplasia in Inflammatory Bowel Disease: When to Stop
被引:2
作者:
Axelrad, Jordan E.
[1
]
Cross, Raymond K.
[2
]
机构:
[1] NYU, Grossman Sch Med, Dept Med, Div Gastroenterol, New York, NY 10012 USA
[2] Univ Maryland, Dept Med, Div Gastroenterol & Hepatol, Sch Med, Baltimore, MD USA
关键词:
colorectal neoplasia;
dysplasia;
colorectal cancer;
inflammatory bowel disease;
ulcerative colitis;
Crohn's disease;
colonoscopy;
EVIDENCE-BASED CONSENSUS;
ULCERATIVE-COLITIS;
AMERICAN-COLLEGE;
CANCER-RISK;
DYSPLASIA;
GUIDELINES;
MANAGEMENT;
ENDOSCOPY;
UPDATE;
METAANALYSIS;
D O I:
10.14309/ajg.0000000000002168
中图分类号:
R57 [消化系及腹部疾病];
学科分类号:
摘要:
Patients with chronic ulcerative and Crohn's colitis are at increased risk for colorectal neoplasia(CRN [dysplasia and cancer]) compared to the general population. Risk factors for CRN include extent of colitis, cumulative inflammatory burden, family history of colorectal cancer, and primary sclerosing cholangitis. Best practices to prevent CRN include control of colonic inflammation, high quality surveillance colonoscopy with or without enhanced imaging techniques, resection of visible dysplasia if possible, and colectomy in patients with unresectable dysplasia, invisible multifocal low grade dysplasia, or invisible high grade dysplasia. Cessation of dysplasia surveillance is individualized and should involve shared decision making based on factors including but not limited to chronologic age, frailty, co-morbid conditions, life expectancy, results of prior surveillance exams, and risk factors for CRN.
引用
收藏
页码:429 / 431
页数:3
相关论文
共 50 条